{"transactions":[{"id":2657103,"issuer":{"id":92707,"kind":"organization","name":"Cyteir Therapeutics, Inc.","symbol":"CYT"},"owners":[{"id":137956,"kind":"organization","name":"Venrock Associates VII, L.P.","position":1,"cik":"0001614766","reported_name":"Venrock Associates VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137957,"kind":"organization","name":"Venrock Partners VII, L.P.","position":2,"cik":"0001614765","reported_name":"Venrock Partners VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137958,"kind":"organization","name":"Venrock Management VII, LLC","position":3,"cik":"0001614686","reported_name":"Venrock Management VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2021-06-23T16:08:27.000Z","date":"2021-06-22","kind":"exercise","acquired":false,"shares":1109368,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock converted into shares of Common Stock at a ratio of 1:3.4088 upon completion of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock converted into shares of Common Stock at a ratio of 1:3.4088 upon completion of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock converted into shares of Common Stock at a ratio of 1:3.4088 upon completion of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock converted into shares of Common Stock at a ratio of 1:3.4088 upon completion of the Issuer's initial public offering. The shares have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":325442},"source":{"system":"sec-edgar","filing":"0001209191-21-042724","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662244/000120919121042724/doc4.xml","form_type":"4"}},{"id":2657102,"issuer":{"id":92707,"kind":"organization","name":"Cyteir Therapeutics, Inc.","symbol":"CYT"},"owners":[{"id":137956,"kind":"organization","name":"Venrock Associates VII, L.P.","position":1,"cik":"0001614766","reported_name":"Venrock Associates VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137957,"kind":"organization","name":"Venrock Partners VII, L.P.","position":2,"cik":"0001614765","reported_name":"Venrock Partners VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137958,"kind":"organization","name":"Venrock Management VII, LLC","position":3,"cik":"0001614686","reported_name":"Venrock Management VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2021-06-23T16:08:27.000Z","date":"2021-06-22","kind":"exercise","acquired":false,"shares":10000000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock converted into shares of Common Stock at a ratio of 1:3.4088 upon completion of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock converted into shares of Common Stock at a ratio of 1:3.4088 upon completion of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock converted into shares of Common Stock at a ratio of 1:3.4088 upon completion of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock converted into shares of Common Stock at a ratio of 1:3.4088 upon completion of the Issuer's initial public offering. The shares have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2933583},"source":{"system":"sec-edgar","filing":"0001209191-21-042724","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662244/000120919121042724/doc4.xml","form_type":"4"}},{"id":2657101,"issuer":{"id":92707,"kind":"organization","name":"Cyteir Therapeutics, Inc.","symbol":"CYT"},"owners":[{"id":137956,"kind":"organization","name":"Venrock Associates VII, L.P.","position":1,"cik":"0001614766","reported_name":"Venrock Associates VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137957,"kind":"organization","name":"Venrock Partners VII, L.P.","position":2,"cik":"0001614765","reported_name":"Venrock Partners VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137958,"kind":"organization","name":"Venrock Management VII, LLC","position":3,"cik":"0001614686","reported_name":"Venrock Management VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-23T16:08:27.000Z","date":"2021-06-22","kind":"exercise","acquired":true,"shares":3259025,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock converted into shares of Common Stock at a ratio of 1:3.4088 upon completion of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 3,009,710 shares of Common Stock held by Venrock Associates VII, L.P. (\"VA VII\") and 249,315 shares of Common Stock held by Venrock Partners VII, L.P. (\"VP VII\"). Venrock Management VII, LLC (\"VM VII\") is the sole general partner of VA VII and VP VII and may be deemed to beneficially own these shares and expressly disclaims beneficial ownership over all shares held by VA VII and VP VII except to the extent of its indirect pecuniary interest therein."}],"balance_after":3259025,"source":{"system":"sec-edgar","filing":"0001209191-21-042724","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662244/000120919121042724/doc4.xml","form_type":"4"}},{"id":3597250,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":137956,"kind":"organization","name":"Venrock Associates VII, L.P.","position":1,"cik":"0001614766","reported_name":"Venrock Associates VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":122870,"kind":"organization","name":"Venrock Healthcare Capital Partners II, L.P.","position":2,"cik":"0001602264","reported_name":"Venrock Healthcare Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137957,"kind":"organization","name":"Venrock Partners VII, L.P.","position":3,"cik":"0001614765","reported_name":"Venrock Partners VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":122871,"kind":"organization","name":"VHCP Co-Investment Holdings II, LLC","position":4,"cik":"0001615983","reported_name":"VHCP Co-Investment Holdings II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137958,"kind":"organization","name":"Venrock Management VII, LLC","position":5,"cik":"0001614686","reported_name":"Venrock Management VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":1948,"kind":"person","name":"Shah Nimish P","position":6,"cik":"0001698082","reported_name":"Shah Nimish P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55710,"kind":"person","name":"Koh Bong Y","position":7,"cik":"0001615979","reported_name":"Koh Bong Y","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106510,"kind":"organization","name":"VHCP Management II, LLC","position":8,"cik":"0001602263","reported_name":"VHCP Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2019-03-13T20:31:48.000Z","date":"2019-03-11","kind":"exercise","acquired":true,"shares":1016492,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."},{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of 382,238 shares of convertible preferred stock held by Venrock Associates VII, L.P., 428,744 shares of convertible preferred stock held by Venrock Healthcare Capital Partners II, L.P., 31,663 shares of convertible preferred stock held by Venrock Partners VII, L.P. and 173,847 shares of convertible preferred stock held by VHCP Co-Investment Holdings II, LLC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Consists of 382,238 shares of convertible preferred stock held by Venrock Associates VII, L.P., 428,744 shares of convertible preferred stock held by Venrock Healthcare Capital Partners II, L.P., 31,663 shares of convertible preferred stock held by Venrock Partners VII, L.P. and 173,847 shares of convertible preferred stock held by VHCP Co-Investment Holdings II, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Venrock Management VII, LLC (\"VM7\") is the sole general partner of Venrock Associates VII, L.P. (\"VA7\") and Venrock Partners VII, L.P. (\"VP7\") and may be deemed to beneficially own these shares and expressly disclaims beneficial ownership over all shares held by VA7 and VP7 except to the extent of its indirect pecuniary interest therein. VHCP Management II, LLC is the general partner of Venrock Healthcare Capital Partners II, L.P. (\"VHCP2\") and the manager of VHCP Co-Investment Holdings II, LLC (\"VHCP Co-Invest 2\"), may be deemed to beneficially own these shares and expressly disclaims beneficial ownership over all shares held by VHCP2 and VHCP Co-Invest 2 except to the extent of its indirect pecuniary interest therein. Bong Koh and Nimish Shah are the managing members of VHCP Management II, LLC. Drs. Koh and Shah expressly disclaim beneficial ownership over all shares held by VHCP2 and VHCP Co-Invest 2 except to the extent of their indirect pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1016492},"source":{"system":"sec-edgar","filing":"0000950103-19-003374","document":"dp103684_4-venrock.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1698082/000095010319003374/dp103684_4-venrock.xml","form_type":"4"}},{"id":3597249,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":137956,"kind":"organization","name":"Venrock Associates VII, L.P.","position":1,"cik":"0001614766","reported_name":"Venrock Associates VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":122870,"kind":"organization","name":"Venrock Healthcare Capital Partners II, L.P.","position":2,"cik":"0001602264","reported_name":"Venrock Healthcare Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137957,"kind":"organization","name":"Venrock Partners VII, L.P.","position":3,"cik":"0001614765","reported_name":"Venrock Partners VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":122871,"kind":"organization","name":"VHCP Co-Investment Holdings II, LLC","position":4,"cik":"0001615983","reported_name":"VHCP Co-Investment Holdings II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137958,"kind":"organization","name":"Venrock Management VII, LLC","position":5,"cik":"0001614686","reported_name":"Venrock Management VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":1948,"kind":"person","name":"Shah Nimish P","position":6,"cik":"0001698082","reported_name":"Shah Nimish P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55710,"kind":"person","name":"Koh Bong Y","position":7,"cik":"0001615979","reported_name":"Koh Bong Y","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106510,"kind":"organization","name":"VHCP Management II, LLC","position":8,"cik":"0001602263","reported_name":"VHCP Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2019-03-13T20:31:48.000Z","date":"2019-03-11","kind":"exercise","acquired":true,"shares":1105529,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."},{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of 745,139 shares of convertible preferred stock held by Venrock Associates VII, L.P., 212,500 shares of convertible preferred stock held by Venrock Healthcare Capital Partners II, L.P., 61,725 shares of convertible preferred stock held by Venrock Partners VII, L.P. and 86,165 shares of convertible preferred stock held by VHCP Co-Investment Holdings II, LLC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Consists of 745,139 shares of convertible preferred stock held by Venrock Associates VII, L.P., 212,500 shares of convertible preferred stock held by Venrock Healthcare Capital Partners II, L.P., 61,725 shares of convertible preferred stock held by Venrock Partners VII, L.P. and 86,165 shares of convertible preferred stock held by VHCP Co-Investment Holdings II, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Venrock Management VII, LLC (\"VM7\") is the sole general partner of Venrock Associates VII, L.P. (\"VA7\") and Venrock Partners VII, L.P. (\"VP7\") and may be deemed to beneficially own these shares and expressly disclaims beneficial ownership over all shares held by VA7 and VP7 except to the extent of its indirect pecuniary interest therein. VHCP Management II, LLC is the general partner of Venrock Healthcare Capital Partners II, L.P. (\"VHCP2\") and the manager of VHCP Co-Investment Holdings II, LLC (\"VHCP Co-Invest 2\"), may be deemed to beneficially own these shares and expressly disclaims beneficial ownership over all shares held by VHCP2 and VHCP Co-Invest 2 except to the extent of its indirect pecuniary interest therein. Bong Koh and Nimish Shah are the managing members of VHCP Management II, LLC. Drs. Koh and Shah expressly disclaim beneficial ownership over all shares held by VHCP2 and VHCP Co-Invest 2 except to the extent of their indirect pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1105529},"source":{"system":"sec-edgar","filing":"0000950103-19-003374","document":"dp103684_4-venrock.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1698082/000095010319003374/dp103684_4-venrock.xml","form_type":"4"}},{"id":3597248,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":137956,"kind":"organization","name":"Venrock Associates VII, L.P.","position":1,"cik":"0001614766","reported_name":"Venrock Associates VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":122870,"kind":"organization","name":"Venrock Healthcare Capital Partners II, L.P.","position":2,"cik":"0001602264","reported_name":"Venrock Healthcare Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137957,"kind":"organization","name":"Venrock Partners VII, L.P.","position":3,"cik":"0001614765","reported_name":"Venrock Partners VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":122871,"kind":"organization","name":"VHCP Co-Investment Holdings II, LLC","position":4,"cik":"0001615983","reported_name":"VHCP Co-Investment Holdings II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137958,"kind":"organization","name":"Venrock Management VII, LLC","position":5,"cik":"0001614686","reported_name":"Venrock Management VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":1948,"kind":"person","name":"Shah Nimish P","position":6,"cik":"0001698082","reported_name":"Shah Nimish P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55710,"kind":"person","name":"Koh Bong Y","position":7,"cik":"0001615979","reported_name":"Koh Bong Y","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106510,"kind":"organization","name":"VHCP Management II, LLC","position":8,"cik":"0001602263","reported_name":"VHCP Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-03-13T20:31:48.000Z","date":"2019-03-11","kind":"exercise","acquired":true,"shares":1016492,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Venrock Management VII, LLC (\"VM7\") is the sole general partner of Venrock Associates VII, L.P. (\"VA7\") and Venrock Partners VII, L.P. (\"VP7\") and may be deemed to beneficially own these shares and expressly disclaims beneficial ownership over all shares held by VA7 and VP7 except to the extent of its indirect pecuniary interest therein. VHCP Management II, LLC is the general partner of Venrock Healthcare Capital Partners II, L.P. (\"VHCP2\") and the manager of VHCP Co-Investment Holdings II, LLC (\"VHCP Co-Invest 2\"), may be deemed to beneficially own these shares and expressly disclaims beneficial ownership over all shares held by VHCP2 and VHCP Co-Invest 2 except to the extent of its indirect pecuniary interest therein. Bong Koh and Nimish Shah are the managing members of VHCP Management II, LLC. Drs. Koh and Shah expressly disclaim beneficial ownership over all shares held by VHCP2 and VHCP Co-Invest 2 except to the extent of their indirect pecuniary interests therein."}],"balance_after":2122021,"source":{"system":"sec-edgar","filing":"0000950103-19-003374","document":"dp103684_4-venrock.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1698082/000095010319003374/dp103684_4-venrock.xml","form_type":"4"}},{"id":3597247,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":137956,"kind":"organization","name":"Venrock Associates VII, L.P.","position":1,"cik":"0001614766","reported_name":"Venrock Associates VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":122870,"kind":"organization","name":"Venrock Healthcare Capital Partners II, L.P.","position":2,"cik":"0001602264","reported_name":"Venrock Healthcare Capital Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137957,"kind":"organization","name":"Venrock Partners VII, L.P.","position":3,"cik":"0001614765","reported_name":"Venrock Partners VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":122871,"kind":"organization","name":"VHCP Co-Investment Holdings II, LLC","position":4,"cik":"0001615983","reported_name":"VHCP Co-Investment Holdings II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137958,"kind":"organization","name":"Venrock Management VII, LLC","position":5,"cik":"0001614686","reported_name":"Venrock Management VII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":1948,"kind":"person","name":"Shah Nimish P","position":6,"cik":"0001698082","reported_name":"Shah Nimish P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55710,"kind":"person","name":"Koh Bong Y","position":7,"cik":"0001615979","reported_name":"Koh Bong Y","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106510,"kind":"organization","name":"VHCP Management II, LLC","position":8,"cik":"0001602263","reported_name":"VHCP Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-03-13T20:31:48.000Z","date":"2019-03-11","kind":"exercise","acquired":true,"shares":1105529,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Venrock Management VII, LLC (\"VM7\") is the sole general partner of Venrock Associates VII, L.P. (\"VA7\") and Venrock Partners VII, L.P. (\"VP7\") and may be deemed to beneficially own these shares and expressly disclaims beneficial ownership over all shares held by VA7 and VP7 except to the extent of its indirect pecuniary interest therein. VHCP Management II, LLC is the general partner of Venrock Healthcare Capital Partners II, L.P. (\"VHCP2\") and the manager of VHCP Co-Investment Holdings II, LLC (\"VHCP Co-Invest 2\"), may be deemed to beneficially own these shares and expressly disclaims beneficial ownership over all shares held by VHCP2 and VHCP Co-Invest 2 except to the extent of its indirect pecuniary interest therein. Bong Koh and Nimish Shah are the managing members of VHCP Management II, LLC. Drs. Koh and Shah expressly disclaim beneficial ownership over all shares held by VHCP2 and VHCP Co-Invest 2 except to the extent of their indirect pecuniary interests therein."}],"balance_after":1105529,"source":{"system":"sec-edgar","filing":"0000950103-19-003374","document":"dp103684_4-venrock.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698082/000095010319003374/dp103684_4-venrock.xml","form_type":"4"}}]}